US$ 25.94
glp-1 parkinson's disease lancet Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's and Diseases | CNS Drugs Beyond insulin: The Intriguing role
Description
Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and prevents inflammatory adipokine expression

Gut Fuel for Natural GLP-1 Pathway Support*

It was initially thought that the anti-diabetic effects of DPP-4 inhibition were predominantly due to the enhanced levels of intact GLP-1 [because the insulinotropic effect of GIP is substantially impaired in subjects with T2DM (42)], but this now seems not to be the case

This FDA-approved medication helps regulate insulin and control cravings, making it easier to eat less and lose weight
